827465

Taro Pharmaceuticals U.S.A., Inc. — FEI 2435212

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 18, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hawthorne, NY (United States)

Citations

IDCFRDescription
241921 CFR 211.198(a)Complaint Handling Procedure
673021 CFR 314.80(b)Failure to develop written procedures
682321 CFR 314.80(c)Failure by applicant to report ADE